期刊文献+

小梁切除术联合丝裂霉素C治疗难治性先天性青光眼的临床观察 被引量:29

Study on mitomycin-C-augmented trabeculectomy in refractory congenital glaucoma
暂未订购
导出
摘要 目的 证实在先天性青光眼常规手术失败的儿童小梁切除术联合丝裂霉素 C(mitomycin- C,MMC)治疗是安全有效的方法。方法  9例 (9眼 )曾行常规手术失败的先天性青光眼儿童在小梁切除术中一次应用 MMC棉片 (0 .2 g· L- 1 )置于手术创面 5 min,平均随访时间 17.6 4mo± 8.41mo(0 .2 5~ 36 mo)。结果 术前平均眼压 4.0 0± 0 .6 3k Pa(3.0 7~4.93k Pa) ,术后平均眼压 1.83± 0 .10 k Pa(1.38~ 2 .0 3k Pa) ,均保持了术前的视力水平 ,成功率 88.89% (8眼 )。基本成功率 11.11% (1眼 )。常见并发症浅前房 8眼 (88.89% )。结论 小梁切除术联合 MMC治疗在常规手术失败的先天性青光眼儿童是安全有效的方法。 Objective To investigate and determine the safety and effect of mitomycin C augmented trabeculectomy on children with refractory congenital glaucoma who failed to recover conventional surgeries.Methods Mitomycin C augmented(0.2g·L -1 for 5 minutes)trabeculectomies were used in charts of 9 eyes of 9 patients during conrentional congenital glaucomal surgeries.Results The mean follow up was 17.64months±8.41 months(range 0.25~36 months).The mean intraocular pressure(IOP)was reduced from 0.40kPa±0 63kPa(range 3.07~4.93kPa)before the surgery to the postoperative level of 0.23kPa±0.10 kPa(range 1.41~2.03kPa).Visual acuities after the surgeries were nearly kept at the same levels as the pre operative ones in all patients.A complete success, record was achieved in 8 eyes(88.89%).Only one eye(11.11%)was classified as a qualified success' record.The common complication as shallow anterior chambers occurred in 8 eyes.Conclusion Mitomycin C augmented trabeculectomy is safe and effective on children with failed traditional trabeculectomy surgeries.
出处 《眼科新进展》 CAS 2000年第2期121-123,共3页 Recent Advances in Ophthalmology
关键词 先天性青光眼 小梁切除术 丝裂霉素C congenital glaucoma trabeculectomy mitomycin C
  • 相关文献

参考文献14

  • 11,AnilK,MandalMD,DavidS,etal.Mitomycin-C-augmentedtrabeculectomyinrefractorycongenitalglaucoma[J].Ophthalmology1997;104∶996-1001.
  • 22,StefanoP,StefanoDP,PaoloP,etal.Normalintraocularpressureinchildren[J].JournalofPediatricOphthalmologyandStrabismus1992;29(2)∶79-84.
  • 33,BeauchampGR,ParksMM.Filteringsurgeryinchildrenbarrierstosuccess[J].Ophthalmology1979;86∶170-180.
  • 44,CaderaW,PachtmanMA,CantorLB,etal.Filteringsurgeryinchildhoodglaucoma[J].OphthalSurg1984;15∶319-322.
  • 55,RudermanJM,WelchDB,SmithMF,etal.Grandomizedstudyof5-fluorouracilandfiltrationsurgery[J].AmJOphthalmol1987;104∶218-224.
  • 66,LeeDA,HershP.Complicationsofsubconjunctival5-fluorouracilfollowingglaucomafilteringsurgery[J].OphthalSurg1987∶187.
  • 77,SinghG,WilsonMR.Mitomycin-Ceyedropsastreatmentforpterygium[J].Ophthalmology1988;95∶813-821.
  • 88,YamamotoT,VaraniJ.Effectsof5-fluorouracilandmitomycin-Conculturedrabbitsubconjunctivalfibroblasts[J].Ophthalmology1990;97∶1204-1210.
  • 99,ChenCW.Enhancedintraocularpressurecontrollingeffectivenessoftrabeculectomybylocalapplicationofmitomycin-C[J].TransAsiaPacificAcadOphthalmol1983;9∶172-177.
  • 1010,PalmerSS.Mitomycin-Casadjunctchemotherapywithtrabeculectomy[J].Ophthalmology1991;98∶317-321.

同被引文献164

引证文献29

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部